SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 1
Ekaterina I. Alexeeva,
Tatiana M. Dvoryakovskaya,
Irina P. Nikishina,
Rina V. Denisova,
Nadezhda S. Podchernyaeva,
Olga A. Sukhorukikh,
Lyubov S. Shubina https://doi.org/10.15690/vsp.v17i1.1853
Abstract
The article presents current data on the etiology, pathogenesis, and epidemiology of systemic lupus erythematosus (SLE). The SLE diagnosis details are considered with a description of each examination technique. Moreover, an assessment of reliability level of both evidence and recommendations for each thesis-recommendation are discussed thoroughly. The aspects of differential diagnosis and criteria for the diagnostic quality of SLE are revealed.
About the Authors
Ekaterina I. Alexeeva
National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared
Tatiana M. Dvoryakovskaya
National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared
Irina P. Nikishina
Nasonova Research Institute of Rheumatology
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared
Rina V. Denisova
National Medical Research Center of Children’s Health
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared
Nadezhda S. Podchernyaeva
Sechenov First Moscow State Medical University
Russian Federation
Disclosure of interest:
Russian Federation
Moscow
Disclosure of interest:
Not declared
Olga A. Sukhorukikh
Center for Healthcare Quality Assessment and Control
Russian Federation
Russian Federation
Lyubov S. Shubina
Center for Healthcare Quality Assessment and Control
Russian Federation
Russian Federation
References
1. Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6(9):538–546. doi: 10.1038/nrrheum.2010.121.
2. Hiraki LT, Benseler SM, Tyrrell PN, et al. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152(4): 550–556. doi: 10.1016/j.jpeds.2007.09.019.
3. Pluchinotta FR, Schiavo B, Vittadello F, et al. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes. Lupus. 2007;16(8):550–555. doi: 10.1177/0961203307080636.
4. Sag E, Tartaglione A, Batu ED, et al. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol. 2014;32(3):440–444.
5. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the systemic lupus erythematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1999;42(7): 1354–1360. doi: 10.1002/1529-0131(199907)42:7<1354::AIDANR8>3.0.CO;2-4.
6. Brunner HI, Silverman ED, Bombardier C, Feldman BM. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2003;49(3):335–341. doi: 10.1002/art.11111.
7. Marks SD, Pilkington C, Woo P, Dillon MJ. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology. 2004;43(9):1186–1189. doi: 10.1093/rheumatology/keh284.
8. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003;49(4):501–507. doi: 10.1002/art.11205.
9. Miettunen PM, Ortiz-Alvarez O, Petty RE, et al. Gender and ethnic origin have no effect on longterm outcome of childhoodonset systemic lupus erythematosus. J Rheumatol. 2004;31(8): 1650–1654.
10. Oshiro AC, Derbes SJ, Stopa AR, Gedalia A. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus. Ann Rheum Dis. 1997; 56(4):272–274. doi: 10.1136/ard.56.4.272.
11. Correa JD, Branco LGA, Calderaro DC, et al. Impact of systemic lupus erythematosus on oral health-related quality of life. Lupus. 2018;27(2):283–289. doi: 10.1177/0961203317719147.
12. Roberts-Thomson PJ, Nikoloutsopoulos T, Cox S, et al. Antinuclear antibody testing in a regional immunopathology laboratory. Immunol Cell Biol. 2003;81(5):409–412. doi: 10.1046/j.14401711.2003.01181.x.
13. Brunner HI, Silverman ED, To T, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus — cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 2002;46(2):436-444. doi: 10.1002/art.10072.
14. Avcin T, Cimaz R, Falcini F, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis. 2002;61(7):608–611. doi: 10.1136/ard.61.7.608.
15. Bogmat LF, Nikonova VV, Shevchenko NS, Bessonova IM. Features of renal dysfunction in children with systemic lupus erythematosus and juvenile idiopathic arthritis. Child's health. 2017;12(6): 663–669. (In Russ). doi: 10.22141/2224-0551.12.6.2017.112834.
16. Lopes VAP, Lourenco DMR, Guariento A, et al. Borderline tuberculoid leprosy in childhood onset systemic lupus erythematosus patient. Lupus. 2015;24(13):1448–1451. doi: 10.1177/0961203315593167.
17. Iwata N, Mori M, Miyamae T, et al. [Sjogren's syndrome associated with childhood-onset systemic lupus erythematosus. (In Japanese).] Nihon Rinsho Meneki Gakkai Kaishi. 2008;31(3):166–171.
18. Lukic A, Lukic IK, Malcic I, et al. Childhood-onset systemic lupus erythematosus in Croatia: demographic, clinical and laboratory features, and factors influencing time to diagnosis. Clin Exp Rheumatol. 2013;31(5):803–812.
19. Hoffman IE, Peene I, Meheus L, et al. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis. 2004;63(9):1155–1158. doi: 10.1136/ard.2003.013417.
20. Gajic-Veljic M, Bonaci-Nikolic B, Lekic B, et al. Importance of low serum DNase I activity and polyspecific anti-neutrophil cytoplasmic antibodies in propylthiouracil-induced lupus-like syndrome. Rheumatology (Oxford). 2015;54(11):2061–2070. doi: 10.1093/rheumatology/kev243.
21. Soboleva MK, Simantovskaya TP, Sobol' NM, et al. Porazhenie pochek pri sistemnoi krasnoi volchanke u detei i podrostkov: osobennosti techeniya i iskhody. Pediatriia. 2012;91(6):22–28. (In Russ).
22. Soboleva MK, Simantovskaja TP, Koltsova EV, et al. Nephrotic syndrome in kids and adolescents with systemic lupus erythematosus. Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriia biologiia, klinicheskaia meditsina. 2013;11(4):136–142. (In Russ).
23. Dube GK, Markowitz GS, Radhakrishnan J, et al. Minimal change disease in systemic lupus erythematosus. Clin Nephrol. 2002;57(2):120–126.
24. Liu MF, Lee JH, Weng TH, Lee YY. Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythematosus with active nephritis. Scand J Rheumatol. 1998;27(4):291–295.
25. Momen T, Madihi Y. Bullous systemic lupus erythematosus and lupus nephritis in a young girl. Oman Med J. 2016;31(6):453–455. doi: 10.5001/omj.2016.91.
26. Gormezano NWS, Kern D, Pereira OL, et al. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients. Lupus. 2017; 26(4):426–430. doi: 10.1177/0961203316676379.
27. Nishihori Y, Yamauchi N, Kuribayashi K, et al. [Severe hemolysis and SIADH-like symptoms induced by vincristine in an ALL patient with liver cirrhosis. (In Japanese).] Rinsho Ketsueki. 2000;41(11):1231–1237.
28. Gomes RC, Silva MF, Kozu K, et al. Features of 847 childhoodonset systemic lupus erythematosus patients in three age groups at diagnosis: a Brazilian multicenter study. Arthritis Care Res (Hoboken). 2016;68(11):1736–1741. doi: 10.1002/acr.22881.
29. Lopes SR, Gormezano NW, Gomes RC, et al. Outcome of 847 childhood-onset systemic lupus erythematousus patients in three age groups. Lupus. 2017;26(9):996–1001. doi: 10.1177/0961203317690616.
30. Bogmat LF, Shevchenko NS, Bessonova IN, et al. Biochemical markers of the functional disorders of the liver in patients with systemic lupus erythematosus. Child's health. 2017;12(4):429–434. (In Russ). doi: 10.22141/22240551.12.4.2017.107621.
31. Lee WS, Lum SH, Lim CB, et al. Characteristics and outcome of autoimmune liver disease in Asian children. Hepatol Int. 2015; 9(2):292–302. doi: 10.1007/s12072-014-9558-0.
32. Adil HF, Horii KA, Hoeltzel MF. Picture of the month — a case of neonatal lupus erythematosus and associated hepatitis. Arch Pediatr Adolesc Med. 2012;166(3):283–284. doi: 10.1001/archpediatrics.2011.789a.
33. Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol. 2010;72(3):223–225. doi: 10.1111/j.1365-3083.2010.02443.x.
34. Deen ME, Porta G, Fiorot FJ, et al. Autoimmune hepatitis and juvenile systemic lupus erythematosus. Lupus. 2009;18(8): 747–751. doi: 10.1177/0961203308100559.
35. Yeh SH, Ni YH, Jeng YM, et al. Emerging importance of autoimmune hepatitis in children in Taiwan, an endemic area for viral hepatitis. Pediatr Neonatol. 2009;50(2):65–69. doi: 10.1016/S1875-9572(09)60035-8.
36. Usta Y, Gurakan F, Akcoren Z, Ozen S. An overlap syndrome involving autoimmune hepatitis and systemic lupus erythematosus in childhood. World J Gastroenterol. 2007;13(19):2764–2767. doi: 10.3748/wjg.v13.i19.2764.
37. Irving KS, Sen D, Tahir H, et al. A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus-a retrospective review of cases. Rheumatology (Oxford). 2007;46(7):1171–1173. doi: 10.1093/rheumatology/kem108.
38. Batal I, Liang K, Bastacky S, et al. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study. Lupus. 2012;21(1):13–26. doi: 10.1177/0961203311422093.
39. Ronchezel MV, Len CA, Spinola e Castro A, et al. Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab. 2001;14(2):165–169. doi: 10.1515/jpem.2001.14.2.165.
40. Mihailova D, Grigorova R, Vassileva B, et al. Autoimmune thyroid disorders in juvenile chronic arthritis and systemic lupus erythematosus. Adv Exp Med Biol. 1999;455:55–60. doi: 10.1007/978-1-4615-4857-7_8.
41. Yucel O. Prevention of Helicobacter pylori infection in childhood. World J Gastroenterol. 2014;20(30):10348–10354. doi: 10.3748/wjg.v20.i30.10348.
42. Tereschenko SY, Olkhovskiy IA. [The diagnostic of chronic infection Helicobacter pylori in children. (In Russ).] Klin Lab Diagn. 2014;(2):48–53.
43. Loizou S, Cofiner C, Weetman AP, Walport MJ. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol. 1992;90(3):434–439. doi: 10.1111/j.1365-2249.1992.tb05864.x.
44. Richer O, Ulinski T, Lemelle I, et al. Abdominal manifestations in childhood-onset systemic lupus erythematosus. Ann Rheum Dis. 2007;66(2):174–178. doi: 10.1136/ard.2005.050070.
45. Zhang M, Li XM, Wang GS, et al. Thyroid cancer in systemic lupus erythematosus: a meta analysis. Int J Clin Exp Pathol. 2014; 7(9):6270–6273.
46. Zhvaniia MA, Gvenetadze TO, Didebulidze KB, Mandzhgaladze ES. Parallels in clinical, laboratory and instrumental data between systemic lupus erythematosus and infectious endocarditis in children. Georgian Med News. 2006;(130):80–84.
47. Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol. 2013;28(3):471–476. doi: 10.1007/s00467012-2342-2.
48. Anuardo P, Verdier M, Gormezano NW, et al. Subclinical pulmonary hypertension in childhood systemic lupus erythematosus associated with minor disease manifestations. Pediatr Cardiol. 2017;38(2):234–239. doi: 10.1007/s00246-016-1504-6.
49. Belenkov IuN, Belichenko OI, Fedina ID. Detection of thrombotic vascular lesions by MR tomography. Kardiologiia. 1987; 27(4):8–11.
50. Shahin AA, Mostafa H, Sami H, Shahin HA. Symptomatic thromb otic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis. Z Rheumatol. 2003; 62(3):246–250. doi: 10.1007/s00393-003-0462-6.
51. Kuczynska-Zardzewialy A, Palasik W, Jedryka-Goral A, Czlonkowska A. [Neurological and psychiatric symptoms in patients with systemic lupus erythematosus. (In Polish).] Neurol Neurochir Pol. 2001;35(5):781–792.
52. Malleson PN. The role of the renal biopsy in childhood onset systemic lupus erythematosus: a viewpoint. Clin Exp Rheumatol. 1989;7(5):563–566.
53. Feder HM Jr, Liu J, Rezuke WN. Kikuchi disease in Connecticut. J Pediatr. 2014;164(1):196–200.e1. doi: 10.1016/j.jpeds. 2013.08.041.
54. Lin HC, Su CY, Huang SC. Kikuchi's disease in Asian children. Pediatrics. 2005;115(1):e92–96. doi: 10.1542/peds.2004-0924.
55. Chuang CH, Yan DC, Chiu CH, et al. Clinical and laboratory manifestations of Kikuchi's disease in children and differences between patients with and without prolonged fever. Pediatr Infect Dis J. 2005;24(6):551–554. doi: 10.1097/01.inf.0000167246.24500.21.
56. Seo JH, Shim HS, Park JJ, et al. A clinical study of histiocytic necrotizing lymphadenitis (Kikuchi's disease) in children. Int J Pediatr Otorhinolaryngol. 2008;72(11):1637–1642. doi: 10.1016/j.ijporl.2008.07.019.
Review
For citations:
Alexeeva E.I., Dvoryakovskaya T.M., Nikishina I.P., Denisova R.V., Podchernyaeva N.S., Sukhorukikh O.A., Shubina L.S. SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL RECOMMENDATIONS. PART 1. Current Pediatrics. 2018;17(1):19-37. (In Russ.) https://doi.org/10.15690/vsp.v17i1.1853
Views:
8113
Email this article 
